TEVA241206C13000
- 0.00
- 0.000.00%
Teva Pharmaceutical Industries Newsroom
Teva Pharmaceutical Says Migraine Prevention Drug Shows Efficacy in Younger Patients
Teva Shares Phase 3 SPACE Trial Results Highlighting The Efficacy And Safety Of AJOVY (Fremanezumab) In Preventing Episodic Migraine In Children And Adolescents
Teva Pharmaceutical Industries Options Spot-On: On December 3rd, 64,730 Contracts Were Traded, With 820.19K Open Interest
Teva Pharmaceutical Industries Options Spot-On: On November 29th, 141.86K Contracts Were Traded, With 674.74K Open Interest
Unusual Options Activity: AMZN, TEVA and Others Attract Market Bets, AMZN V/OI Ratio Reaches 859.4
Unusual Options Activity: TEVA, IONQ and Others Attract Market Bets, TEVA V/OI Ratio Reaches 253.5
Press Release: Medincell: Videoconference and Publication of Half-year Financial Results, Tuesday, December 10th, 2024
Teva Pharmaceutical Industries Options Spot-On: On November 27th, 63,244 Contracts Were Traded, With 622.89K Open Interest
Unusual Options Activity: AAL, COIN and Others Attract Market Bets, AAL V/OI Ratio Reaches 75.0
Teva to Present at the 7th Annual Evercore ISI HealthCONx Conference
Teva Pharmaceutical (TEVA): The Global Leader in Affordable Medicine Under $25
Goldman's Hedge Fund VIP List: AMZN, VST, CRM, BABA, and More
Unusual Options Activity: TEVA, MDT and Others Attract Market Bets, TEVA V/OI Ratio Reaches 322.6
Teva Pharmaceutical Industries (NYSE:TEVA) Shareholders Are Still up 85% Over 3 Years Despite Pulling Back 4.0% in the Past Week
US Manufacturing Index Rises To 43, Highest Since 2020
Plant-Based API Market Poised To Hit $52 Billion By 2034, Driven By Psychedelics And Cannabinoids
Unusual Options Activity: CCK, CMG and Others Attract Market Bets, CCK V/OI Ratio Reaches 179.2
Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory
Druckenmiller's Duquesne Closes Some Media Holdings, Loads Into Regional Banks, Among Q3 Trades
Assertio Stock Gains Amid Clash With Activist Investor, Q3 Earnings